Samuels Theodore R. Ii - Net Worth and Insider Trading

Samuels Theodore R. Ii Net Worth

The estimated net worth of Samuels Theodore R. Ii is at least $5 Million dollars as of 2025-05-23. Samuels Theodore R. Ii is the Director of Centene Corp and owns about 36,623 shares of Centene Corp (CNC) stock worth over $2 Million. Samuels Theodore R. Ii is the Director of Bristol-Myers Squibb Co and owns about 35,500 shares of Bristol-Myers Squibb Co (BMY) stock worth over $2 Million. Samuels Theodore R. Ii is also the Director of Perrigo Co PLC and owns about 32,408 shares of Perrigo Co PLC (PRGO) stock worth over $855,571. Details can be seen in Samuels Theodore R. Ii's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samuels Theodore R. Ii has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Samuels Theodore R. Ii

To

Samuels Theodore R. Ii Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuels Theodore R. Ii owns 5 companies in total, including Bristol-Myers Squibb Co (BMY) , Stamps.com Inc (STMP) , and Perrigo Co PLC (PRGO) among others .

Click here to see the complete history of Samuels Theodore R. Ii’s form 4 insider trades.

Insider Ownership Summary of Samuels Theodore R. Ii

Ticker Company Transaction Date Type of Owner
BMY Bristol-Myers Squibb Co 2023-11-20 director
STMP Stamps.com Inc 2020-06-10 director
PRGO Perrigo Co PLC 2020-11-09 director
LIMIT LIMIT 2024-12-13 director
LIMIT LIMIT 2023-07-17 director

Samuels Theodore R. Ii Latest Holdings Summary

Samuels Theodore R. Ii currently owns a total of 3 stocks. Among these stocks, Samuels Theodore R. Ii owns 36,623 shares of Centene Corp (CNC) as of December 13, 2024, with a value of $2 Million and a weighting of 45.72%. Samuels Theodore R. Ii owns 35,500 shares of Bristol-Myers Squibb Co (BMY) as of November 20, 2023, with a value of $2 Million and a weighting of 35.89%. Samuels Theodore R. Ii also owns 32,408 shares of Perrigo Co PLC (PRGO) as of November 9, 2020, with a value of $855,571 and a weighting of 18.39%.

Latest Holdings of Samuels Theodore R. Ii

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CNC Centene Corp 2024-12-13 36,623 58.07 2,126,698
BMY Bristol-Myers Squibb Co 2023-11-20 35,500 47.03 1,669,565
PRGO Perrigo Co PLC 2020-11-09 32,408 26.40 855,571

Holding Weightings of Samuels Theodore R. Ii


Samuels Theodore R. Ii Form 4 Trading Tracker

According to the SEC Form 4 filings, Samuels Theodore R. Ii has made a total of 3 transactions in Centene Corp (CNC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Centene Corp is the acquisition of 5,000 shares on December 13, 2024, which cost Samuels Theodore R. Ii around $294,300.

According to the SEC Form 4 filings, Samuels Theodore R. Ii has made a total of 1 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 8,500 shares on November 20, 2023, which cost Samuels Theodore R. Ii around $423,385.

According to the SEC Form 4 filings, Samuels Theodore R. Ii has made a total of 1 transactions in Perrigo Co PLC (PRGO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Perrigo Co PLC is the acquisition of 4,500 shares on November 9, 2020, which cost Samuels Theodore R. Ii around $211,095.

Insider Trading History of Samuels Theodore R. Ii

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samuels Theodore R. Ii Trading Performance

GuruFocus tracks the stock performance after each of Samuels Theodore R. Ii's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samuels Theodore R. Ii is 0.62%. GuruFocus also compares Samuels Theodore R. Ii's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samuels Theodore R. Ii within 3 months outperforms 5 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samuels Theodore R. Ii's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samuels Theodore R. Ii

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
7 out of 11 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.32 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.18 LIMIT LIMIT LIMIT LIMIT LIMIT

Samuels Theodore R. Ii Ownership Network

Ownership Network List of Samuels Theodore R. Ii

No Data

Ownership Network Relation of Samuels Theodore R. Ii

Insider Network Chart


Samuels Theodore R. Ii Owned Company Details

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Samuels Theodore R. Ii is the director of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include Chief Medical Offr. & Drug Dev. Samit Hirawat , EVP & Chief Commercial Officer Christopher S. Boerner , and EVP & Corporate Affairs Cari Gallman .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Samuels Theodore R. Ii made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 7,903 shares made by Samit Hirawat , a net purchase of 7,071 shares made by Christopher S. Boerner , and a net sale of 700 shares made by .

In summary, during the past 3 months, insiders sold 97 shares of Bristol-Myers Squibb Co (BMY) in total and bought 4,250 shares, with a net purchase of 4,153 shares. During the past 18 months, 797 shares of Bristol-Myers Squibb Co (BMY) were sold and 14,974 shares were bought by its insiders, resulting in a net purchase of 14,177 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Samuels Theodore R. Ii Mailing Address

Above is the net worth, insider trading, and ownership report for Samuels Theodore R. Ii. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Samuels Theodore R. Ii's mailing address is: El Segundo Ca 90245.